|
OMIM |
Link |
Information gain |
01 |
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00374909
|
|
|
porokeratosis of mibelli
|
[NCBI]
|
0.00213118
|
|
|
xm system
|
[NCBI]
|
0.00141296
|
|
|
DFN2
|
[NCBI]
|
0.00128598
|
|
|
SLE
|
[NCBI]
|
0.00125722
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.00119189
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.00111717
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.00100243
|
|
|
WM1
|
[NCBI]
|
0.000915676
|
|
|
GPS
|
[NCBI]
|
0.00060686
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
0.000531557
|
|
|
australia antigen
|
[NCBI]
|
0.000479907
|
|
|
oguchi disease
|
[NCBI]
|
0.000393196
|
|
|
MBP
|
[NCBI]
|
0.000360366
|
|
|
CEACAM5
|
[NCBI]
|
0.000321357
|
|
|
von willebrand disease
|
[NCBI]
|
0.000312162
|
|
|
SSFA1
|
[NCBI]
|
0.000308749
|
|
|
MUC1
|
[NCBI]
|
0.000250504
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
0.000239871
|
|
|
RA
|
[NCBI]
|
0.000211842
|
|
|
xh antigen
|
[NCBI]
|
0.00019646
|
|
|
surface antigen, glycoprotein 75
|
[NCBI]
|
0.00019646
|
|
|
SAG
|
[NCBI]
|
0.000194662
|
|
|
VRNI
|
[NCBI]
|
0.00018394
|
|
|
F3
|
[NCBI]
|
0.000183856
|
|
|
hemophilia a
|
[NCBI]
|
0.000173585
|
|
|
CF
|
[NCBI]
|
0.000169735
|
|
|
TFPI
|
[NCBI]
|
0.000130449
|
|
|
F5F8D
|
[NCBI]
|
0.000126769
|
|
|
ACPP
|
[NCBI]
|
0.000122045
|
|
|
PROCR
|
[NCBI]
|
0.000122012
|
|
|
HLA-A
|
[NCBI]
|
0.000120143
|
|
|
factor ix and factor xi, combined deficiency of
|
[NCBI]
|
0.000119894
|
|
|
hypersensitivity pneumonitis, familial
|
[NCBI]
|
0.000119894
|
|
|
lymphokine deficiency
|
[NCBI]
|
0.000119894
|
|
|
hyperheparinemia
|
[NCBI]
|
0.000119894
|
|
|
citrulline transport defect
|
[NCBI]
|
0.000119894
|
|
|
blood group--en
|
[NCBI]
|
0.000119894
|
|
|
factor vii deficiency
|
[NCBI]
|
0.000110638
|
|
|
AL-A1
|
[NCBI]
|
0.000110027
|
|
|
GFAP
|
[NCBI]
|
0.000104423
|
|
|
PCNT1
|
[NCBI]
|
9.72819e-05
|
|
|
CSPG4
|
[NCBI]
|
9.72819e-05
|
|
|
CVID
|
[NCBI]
|
9.6359e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
9.61692e-05
|
|
|
PCNT2
|
[NCBI]
|
9.21122e-05
|
|
|
factors viii, ix and xi, combined deficiency of
|
[NCBI]
|
8.84212e-05
|
|
|
WD
|
[NCBI]
|
8.84212e-05
|
|
|
LXN
|
[NCBI]
|
8.00844e-05
|
|
|
VEGF
|
[NCBI]
|
7.88859e-05
|
|
|
buerger disease
|
[NCBI]
|
7.66157e-05
|
|
|
IL2
|
[NCBI]
|
7.16514e-05
|
|
|
MG
|
[NCBI]
|
6.90602e-05
|
|
|
XS
|
[NCBI]
|
6.89907e-05
|
|
|
RD
|
[NCBI]
|
6.89907e-05
|
|
|
PRL
|
[NCBI]
|
6.6525e-05
|
|
|
YT
|
[NCBI]
|
6.33512e-05
|
|
|
TG
|
[NCBI]
|
6.1713e-05
|
|
|
LAG5
|
[NCBI]
|
6.15396e-05
|
|
|
PNMA2
|
[NCBI]
|
6.1402e-05
|
|
|
CPB2
|
[NCBI]
|
6.08213e-05
|
|
|
fraser syndrome
|
[NCBI]
|
5.8881e-05
|
|
|
PF4
|
[NCBI]
|
5.57144e-05
|
|
|
AVP
|
[NCBI]
|
5.40244e-05
|
|
|
ADRBK2
|
[NCBI]
|
5.11938e-05
|
|
|
EGF
|
[NCBI]
|
4.99856e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
4.92978e-05
|
|
|
amyloidosis v
|
[NCBI]
|
4.92978e-05
|
|
|
RHCE
|
[NCBI]
|
4.89847e-05
|
|
|
sarcoidosis
|
[NCBI]
|
4.68789e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
4.65896e-05
|
|
|
CRH
|
[NCBI]
|
4.52495e-05
|
|
|
HEMB
|
[NCBI]
|
4.49784e-05
|
|
|
MAG
|
[NCBI]
|
4.48053e-05
|
|
|
pta deficiency
|
[NCBI]
|
4.47681e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
4.47147e-05
|
|
|
EIF3A
|
[NCBI]
|
4.34343e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
4.27586e-05
|
|
|
CGD
|
[NCBI]
|
4.14748e-05
|
|
|
ARRB1
|
[NCBI]
|
4.10204e-05
|
|
|
AMC
|
[NCBI]
|
4.09757e-05
|
|
|
Ii
|
[NCBI]
|
4.09757e-05
|
|
|
IFD
|
[NCBI]
|
4.09757e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.07116e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
3.93395e-05
|
|
|
KLRA1
|
[NCBI]
|
3.90628e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.90381e-05
|
|
|
EGFR
|
[NCBI]
|
3.82704e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
3.78288e-05
|
|
|
NPY
|
[NCBI]
|
3.60821e-05
|
|
|
PSMB9
|
[NCBI]
|
3.59945e-05
|
|
|
CCK
|
[NCBI]
|
3.55776e-05
|
|
|
RP
|
[NCBI]
|
3.43187e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
3.38972e-05
|
|
|
polycythemia vera
|
[NCBI]
|
3.38972e-05
|
|
|
blood group, p system
|
[NCBI]
|
3.27489e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
3.27489e-05
|
|
|
factor x deficiency
|
[NCBI]
|
3.21564e-05
|
|
|
EBR1
|
[NCBI]
|
3.16674e-05
|
|
|
OLIG2
|
[NCBI]
|
3.0864e-05
|
|
|
ICOS
|
[NCBI]
|
3.0864e-05
|
|
|
ARRB2
|
[NCBI]
|
3.0864e-05
|
|
|
PNMA1
|
[NCBI]
|
3.06979e-05
|
|
|
GOLPH4
|
[NCBI]
|
3.06979e-05
|
|
|
hom-tes-103 gene
|
[NCBI]
|
3.06979e-05
|
|
|
ZWINTAS
|
[NCBI]
|
3.06979e-05
|
|
|
MPHOSPH9
|
[NCBI]
|
3.06979e-05
|
|
|
NLRP5
|
[NCBI]
|
3.06979e-05
|
|
|
CENPD
|
[NCBI]
|
3.06979e-05
|
|
|
LUZP4
|
[NCBI]
|
3.06979e-05
|
|
|
ACRV1
|
[NCBI]
|
3.06979e-05
|
|
|
CGL2
|
[NCBI]
|
3.06459e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.96575e-05
|
|
|
TAP1
|
[NCBI]
|
2.93635e-05
|
|
|
CD1D
|
[NCBI]
|
2.80559e-05
|
|
|
THY1
|
[NCBI]
|
2.74604e-05
|
|
|
FUT2
|
[NCBI]
|
2.63656e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
2.62636e-05
|
|
|
LCK
|
[NCBI]
|
2.586e-05
|
|
|
CEACAM6
|
[NCBI]
|
2.586e-05
|
|
|
MIF
|
[NCBI]
|
2.586e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
2.53788e-05
|
|
|
FGF2
|
[NCBI]
|
2.52457e-05
|
|
|
XK
|
[NCBI]
|
2.49198e-05
|
|
|
HSAN3
|
[NCBI]
|
2.47796e-05
|
|
|
ATS
|
[NCBI]
|
2.47796e-05
|
|
|
EPO
|
[NCBI]
|
2.41705e-05
|
|
|
SCIDX1
|
[NCBI]
|
2.4084e-05
|
|
|
TH
|
[NCBI]
|
2.3537e-05
|
|
|
CLL
|
[NCBI]
|
2.34164e-05
|
|
|
S5
|
[NCBI]
|
2.32918e-05
|
|
|
USP29
|
[NCBI]
|
2.32918e-05
|
|
|
XE7Y
|
[NCBI]
|
2.32918e-05
|
|
|
IFI44
|
[NCBI]
|
2.32918e-05
|
|
|
PNMA3
|
[NCBI]
|
2.32918e-05
|
|
|
MPHOSPH6
|
[NCBI]
|
2.32918e-05
|
|
|
pseudoautosomal gene xe7
|
[NCBI]
|
2.32918e-05
|
|
|
IQWD1
|
[NCBI]
|
2.32918e-05
|
|
|
IFI30
|
[NCBI]
|
2.32918e-05
|
|
|
CD4
|
[NCBI]
|
2.28986e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
2.27751e-05
|
|
|
ACHE
|
[NCBI]
|
2.23439e-05
|
|
|
CYBB
|
[NCBI]
|
2.1225e-05
|
|
|
AR
|
[NCBI]
|
2.11462e-05
|
|
|
MPHOSPH10
|
[NCBI]
|
2.05072e-05
|
|
|
SPAG6
|
[NCBI]
|
2.05072e-05
|
|
|
MAGEC1
|
[NCBI]
|
2.05072e-05
|
|
|
COL25A1
|
[NCBI]
|
2.05072e-05
|
|
|
EPHB6
|
[NCBI]
|
2.05072e-05
|
|
|
UAP1
|
[NCBI]
|
2.05072e-05
|
|
|
IHG
|
[NCBI]
|
2.05072e-05
|
|
|
FABP3
|
[NCBI]
|
2.03449e-05
|
|
|
NPPA
|
[NCBI]
|
2.02766e-05
|
|
|
BDNF
|
[NCBI]
|
1.87194e-05
|
|
|
MPHOSPH1
|
[NCBI]
|
1.87049e-05
|
|
|
ARR3
|
[NCBI]
|
1.87049e-05
|
|
|
CISH
|
[NCBI]
|
1.87049e-05
|
|
|
ADAMTS5
|
[NCBI]
|
1.87049e-05
|
|
|
NDE1
|
[NCBI]
|
1.87049e-05
|
|
|
TIA1
|
[NCBI]
|
1.87049e-05
|
|
|
RNY1
|
[NCBI]
|
1.87049e-05
|
|
|
CCR8
|
[NCBI]
|
1.87049e-05
|
|
|
RNY3
|
[NCBI]
|
1.87049e-05
|
|
|
ZRF1
|
[NCBI]
|
1.87049e-05
|
|
|
APOE
|
[NCBI]
|
1.84672e-05
|
|
|
LPA
|
[NCBI]
|
1.78926e-05
|
|
|
CSF2
|
[NCBI]
|
1.76796e-05
|
|
|
hook, drosophila, homolog of, 1
|
[NCBI]
|
1.73693e-05
|
|
|
CPA4
|
[NCBI]
|
1.73693e-05
|
|
|
AP3B2
|
[NCBI]
|
1.73693e-05
|
|
|
TCF7
|
[NCBI]
|
1.73693e-05
|
|
|
LMOD1
|
[NCBI]
|
1.73693e-05
|
|
|
PSMB10
|
[NCBI]
|
1.73693e-05
|
|
|
NOL1
|
[NCBI]
|
1.73693e-05
|
|
|
PIK3CD
|
[NCBI]
|
1.73693e-05
|
|
|
B4GALNT2
|
[NCBI]
|
1.73693e-05
|
|
|
MRC1
|
[NCBI]
|
1.73693e-05
|
|
|
CCL21
|
[NCBI]
|
1.70688e-05
|
|
|
MB
|
[NCBI]
|
1.69783e-05
|
|
|
IGHG1
|
[NCBI]
|
1.64967e-05
|
|
|
prostaglandin d2 synthase, hematopoietic
|
[NCBI]
|
1.63084e-05
|
|
|
THOP1
|
[NCBI]
|
1.63084e-05
|
|
|
LW
|
[NCBI]
|
1.63084e-05
|
|
|
GDF1
|
[NCBI]
|
1.63084e-05
|
|
|
LPL
|
[NCBI]
|
1.56369e-05
|
|
|
FALZ
|
[NCBI]
|
1.54291e-05
|
|
|
OMG
|
[NCBI]
|
1.54291e-05
|
|
|
TAP2
|
[NCBI]
|
1.54291e-05
|
|
|
HIST1H1C
|
[NCBI]
|
1.54291e-05
|
|
|
OLIG1
|
[NCBI]
|
1.54291e-05
|
|
|
HPA-2
|
[NCBI]
|
1.54291e-05
|
|
|
CD
|
[NCBI]
|
1.49907e-05
|
|
|
F2
|
[NCBI]
|
1.49729e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.46929e-05
|
|
|
HAGH
|
[NCBI]
|
1.46788e-05
|
|
|
NASP
|
[NCBI]
|
1.46788e-05
|
|
|
CPA1
|
[NCBI]
|
1.46788e-05
|
|
|
WBSCR5
|
[NCBI]
|
1.46788e-05
|
|
|
TNFRSF18
|
[NCBI]
|
1.46788e-05
|
|
|
TTK
|
[NCBI]
|
1.46788e-05
|
|
|
CAT
|
[NCBI]
|
1.44975e-05
|
|
|
PTH
|
[NCBI]
|
1.43719e-05
|
|
|
PCNA
|
[NCBI]
|
1.43616e-05
|
|
|
ND
|
[NCBI]
|
1.43365e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
1.43365e-05
|
|
|
CHAT
|
[NCBI]
|
1.4092e-05
|
|
|
CCR7
|
[NCBI]
|
1.4025e-05
|
|
|
CENPC1
|
[NCBI]
|
1.4025e-05
|
|
|
CACNB2
|
[NCBI]
|
1.4025e-05
|
|
|
ILF3
|
[NCBI]
|
1.4025e-05
|
|
|
BLR1
|
[NCBI]
|
1.4025e-05
|
|
|
VEGFB
|
[NCBI]
|
1.4025e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.35728e-05
|
|
|
CXCL9
|
[NCBI]
|
1.34462e-05
|
|
|
TNFSF13
|
[NCBI]
|
1.34462e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
1.34462e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.3352e-05
|
|
|
CXCL10
|
[NCBI]
|
1.29272e-05
|
|
|
CD38
|
[NCBI]
|
1.29272e-05
|
|
|
EDG1
|
[NCBI]
|
1.29272e-05
|
|
|
GRIP1
|
[NCBI]
|
1.29272e-05
|
|
|
XG
|
[NCBI]
|
1.29272e-05
|
|
|
PAG1
|
[NCBI]
|
1.2457e-05
|
|
|
GTF2H1
|
[NCBI]
|
1.2457e-05
|
|
|
IL10
|
[NCBI]
|
1.24393e-05
|
|
|
AD
|
[NCBI]
|
1.21107e-05
|
|
|
C5R1
|
[NCBI]
|
1.20276e-05
|
|
|
OTX2
|
[NCBI]
|
1.20276e-05
|
|
|
XBP1
|
[NCBI]
|
1.20276e-05
|
|
|
MARCO
|
[NCBI]
|
1.16327e-05
|
|
|
FYN
|
[NCBI]
|
1.16327e-05
|
|
|
GAD1
|
[NCBI]
|
1.16327e-05
|
|
|
STAT6
|
[NCBI]
|
1.15693e-05
|
|
|
COL9A1
|
[NCBI]
|
1.12672e-05
|
|
|
JARID1D
|
[NCBI]
|
1.12672e-05
|
|
|
CD99
|
[NCBI]
|
1.12672e-05
|
|
|
ITGA2
|
[NCBI]
|
1.09273e-05
|
|
|
CD209
|
[NCBI]
|
1.09273e-05
|
|
|
FUT1
|
[NCBI]
|
1.09273e-05
|
|
|
C5
|
[NCBI]
|
1.06098e-05
|
|
|
CCL19
|
[NCBI]
|
1.06098e-05
|
|
|
MPI
|
[NCBI]
|
1.06098e-05
|
|
|
OCP
|
[NCBI]
|
1.0465e-05
|
|
|
CRX
|
[NCBI]
|
1.03119e-05
|
|
|
GNB3
|
[NCBI]
|
1.03119e-05
|
|
|
MOG
|
[NCBI]
|
1.03119e-05
|
|
|
JK
|
[NCBI]
|
1.03119e-05
|
|
|
FCGR3A
|
[NCBI]
|
1.03119e-05
|
|
|
PAEP
|
[NCBI]
|
1.01613e-05
|
|
|
CCL18
|
[NCBI]
|
1.00317e-05
|
|
|
IL15
|
[NCBI]
|
1.00317e-05
|
|
|
CXCL13
|
[NCBI]
|
1.00317e-05
|
|
|
CD40
|
[NCBI]
|
1.00317e-05
|
|
|
KEL
|
[NCBI]
|
1.00317e-05
|
|
|
GAD2
|
[NCBI]
|
9.76705e-06
|
|
|
PGM3
|
[NCBI]
|
9.76705e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
9.76705e-06
|
|
|
Ge
|
[NCBI]
|
9.76705e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
9.73508e-06
|
|
|
LAMB3
|
[NCBI]
|
9.51655e-06
|
|
|
CASP3
|
[NCBI]
|
9.27882e-06
|
|
|
MMP12
|
[NCBI]
|
9.27882e-06
|
|
|
CCL25
|
[NCBI]
|
9.27882e-06
|
|
|
LRP2
|
[NCBI]
|
9.27882e-06
|
|
|
PTK2
|
[NCBI]
|
9.22304e-06
|
|
|
PLSCR1
|
[NCBI]
|
9.05269e-06
|
|
|
ITGB1
|
[NCBI]
|
9.05269e-06
|
|
|
RHD
|
[NCBI]
|
8.83716e-06
|
|
|
TNFSF6
|
[NCBI]
|
8.60965e-06
|
|
|
AACT
|
[NCBI]
|
8.43444e-06
|
|
|
MYD88
|
[NCBI]
|
8.06478e-06
|
|
|
CD8A
|
[NCBI]
|
7.89085e-06
|
|
|
KLK3
|
[NCBI]
|
7.73321e-06
|
|
|
TPO
|
[NCBI]
|
7.67479e-06
|
|
|
RHO
|
[NCBI]
|
7.60228e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
7.56236e-06
|
|
|
PLD2
|
[NCBI]
|
7.56236e-06
|
|
|
GAS
|
[NCBI]
|
7.40695e-06
|
|
|
LYZ
|
[NCBI]
|
7.40695e-06
|
|
|
GP1BA
|
[NCBI]
|
7.40695e-06
|
|
|
ENPP1
|
[NCBI]
|
7.40695e-06
|
|
|
SLC3A2
|
[NCBI]
|
7.40695e-06
|
|
|
RBP3
|
[NCBI]
|
7.11201e-06
|
|
|
IGKC
|
[NCBI]
|
7.11201e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
6.97185e-06
|
|
|
BCL6
|
[NCBI]
|
6.97185e-06
|
|
|
MARCKS
|
[NCBI]
|
6.97185e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
6.91773e-06
|
|
|
GSN
|
[NCBI]
|
6.83619e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
6.77692e-06
|
|
|
ACP1
|
[NCBI]
|
6.70479e-06
|
|
|
PI
|
[NCBI]
|
6.63191e-06
|
|
|
MPO
|
[NCBI]
|
6.59861e-06
|
|
|
PAI1
|
[NCBI]
|
6.5774e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
6.5774e-06
|
|
|
GNRH1
|
[NCBI]
|
6.48845e-06
|
|
|
PDE6B
|
[NCBI]
|
6.45383e-06
|
|
|
NGFB
|
[NCBI]
|
6.38712e-06
|
|
|
AFP
|
[NCBI]
|
6.35837e-06
|
|
|
ABO
|
[NCBI]
|
6.33387e-06
|
|
|
GLB1
|
[NCBI]
|
6.21735e-06
|
|
|
GDNF
|
[NCBI]
|
6.2049e-06
|
|
|
TERT
|
[NCBI]
|
6.18201e-06
|
|
|
PPARA
|
[NCBI]
|
6.1069e-06
|
|
|
LIFR
|
[NCBI]
|
6.10409e-06
|
|
|
TCRG
|
[NCBI]
|
6.10409e-06
|
|
|
APS1
|
[NCBI]
|
6.10321e-06
|
|
|
PKLR
|
[NCBI]
|
5.99394e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
5.88676e-06
|
|
|
SPP1
|
[NCBI]
|
5.8512e-06
|
|
|
HDC
|
[NCBI]
|
5.81833e-06
|
|
|
DES
|
[NCBI]
|
5.68077e-06
|
|
|
ACADS
|
[NCBI]
|
5.68077e-06
|
|
|
GIP
|
[NCBI]
|
5.56733e-06
|
|
|
GPI
|
[NCBI]
|
5.44703e-06
|
|
|
C4B
|
[NCBI]
|
5.39092e-06
|
|
|
HEXB
|
[NCBI]
|
5.29899e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
5.29899e-06
|
|
|
DHFR
|
[NCBI]
|
5.27895e-06
|
|
|
HS
|
[NCBI]
|
5.12161e-06
|
|
|
TF
|
[NCBI]
|
4.95785e-06
|
|
|
RIPK1
|
[NCBI]
|
4.95231e-06
|
|
|
EPOR
|
[NCBI]
|
4.7515e-06
|
|
|
ARF1
|
[NCBI]
|
4.71223e-06
|
|
|
TFRC
|
[NCBI]
|
4.63564e-06
|
|
|
KIT
|
[NCBI]
|
4.63564e-06
|
|
|
PSEN2
|
[NCBI]
|
4.56068e-06
|
|
|
F13A1
|
[NCBI]
|
4.48727e-06
|
|
|
BCL2
|
[NCBI]
|
4.41539e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
4.30199e-06
|
|
|
POMC
|
[NCBI]
|
4.25679e-06
|
|
|
GRB2
|
[NCBI]
|
4.142e-06
|
|
|
ALPS
|
[NCBI]
|
4.00485e-06
|
|
|
CNTF
|
[NCBI]
|
3.77824e-06
|
|
|
SST
|
[NCBI]
|
3.70359e-06
|
|
|
MAPK3
|
[NCBI]
|
3.6548e-06
|
|
|
JAK3
|
[NCBI]
|
3.6548e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
3.48037e-06
|
|
|
PTHLH
|
[NCBI]
|
3.32481e-06
|
|
|
CCL2
|
[NCBI]
|
3.23321e-06
|
|
|
COMP
|
[NCBI]
|
3.22557e-06
|
|
|
IL3
|
[NCBI]
|
3.18446e-06
|
|
|
FTD
|
[NCBI]
|
3.17477e-06
|
|
|
BTK
|
[NCBI]
|
3.13652e-06
|
|
|
PLG
|
[NCBI]
|
3.12699e-06
|
|
|
FGA
|
[NCBI]
|
2.95245e-06
|
|
|
DFSP
|
[NCBI]
|
2.83286e-06
|
|
|
UGB
|
[NCBI]
|
2.82197e-06
|
|
|
HEXA
|
[NCBI]
|
2.82197e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.82197e-06
|
|
|
HRG
|
[NCBI]
|
2.6177e-06
|
|
|
RNASE3
|
[NCBI]
|
2.51637e-06
|
|
|
CCL22
|
[NCBI]
|
2.46516e-06
|
|
|
FGF1
|
[NCBI]
|
2.42844e-06
|
|
|
TYR
|
[NCBI]
|
2.28685e-06
|
|
|
SRC
|
[NCBI]
|
2.15326e-06
|
|
|
IL4
|
[NCBI]
|
2.08928e-06
|
|
|
homocystinuria
|
[NCBI]
|
1.96662e-06
|
|
|
ALB
|
[NCBI]
|
1.90722e-06
|
|
|
SHBG
|
[NCBI]
|
1.88094e-06
|
|
|
PIGR
|
[NCBI]
|
1.85062e-06
|
|
|
ESR1
|
[NCBI]
|
1.76772e-06
|
|
|
ACP5
|
[NCBI]
|
1.76321e-06
|
|
|
SOD2
|
[NCBI]
|
1.74544e-06
|
|
|
TLR9
|
[NCBI]
|
1.56245e-06
|
|
|
MITF
|
[NCBI]
|
1.53831e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.51025e-06
|
|
|
PCI
|
[NCBI]
|
1.42229e-06
|
|
|
PG
|
[NCBI]
|
1.35627e-06
|
|
|
PLAUR
|
[NCBI]
|
1.35627e-06
|
|
|
CTGF
|
[NCBI]
|
1.27168e-06
|
|
|
VIP
|
[NCBI]
|
1.26217e-06
|
|
|
OMP
|
[NCBI]
|
1.25184e-06
|
|
|
WAS
|
[NCBI]
|
1.21634e-06
|
|
|
TNF
|
[NCBI]
|
1.19315e-06
|
|
|
ADA
|
[NCBI]
|
1.16556e-06
|
|
|
temporal arteritis
|
[NCBI]
|
1.12365e-06
|
|
|
HP
|
[NCBI]
|
1.07629e-06
|
|
|
KDR
|
[NCBI]
|
1.06235e-06
|
|
|
TNC
|
[NCBI]
|
1.02732e-06
|
|
|
GAPDH
|
[NCBI]
|
9.0004e-07
|
|
|
PSEN1
|
[NCBI]
|
7.91698e-07
|
|
|
XDH
|
[NCBI]
|
6.78861e-07
|
|
|
GAL
|
[NCBI]
|
6.30086e-07
|
|
|
ACADM
|
[NCBI]
|
6.21813e-07
|
|
|
PGR
|
[NCBI]
|
5.9891e-07
|
|
|
ABCC1
|
[NCBI]
|
5.26516e-07
|
|
|
SRF
|
[NCBI]
|
5.26516e-07
|
|
|
AIS
|
[NCBI]
|
3.92939e-07
|
|
|
APOB
|
[NCBI]
|
3.58083e-07
|
|
|
ADCYAP1
|
[NCBI]
|
3.38808e-07
|
|
|
PRNP
|
[NCBI]
|
2.76087e-07
|
|
|
OSM
|
[NCBI]
|
2.01656e-07
|
|
|
AT
|
[NCBI]
|
1.7277e-07
|
|
|
ABP1
|
[NCBI]
|
1.66784e-07
|
|
|
INS
|
[NCBI]
|
1.12178e-07
|
|
|
TLR2
|
[NCBI]
|
5.10993e-08
|
|
|
MBL2
|
[NCBI]
|
5.08261e-08
|
|
|
LRP1
|
[NCBI]
|
5.08261e-08
|
|
|
PNMT
|
[NCBI]
|
3.65559e-08
|
|
|
TSD
|
[NCBI]
|
3.50128e-08
|
|
|
GTS
|
[NCBI]
|
2.27064e-08
|
|
|
BL
|
[NCBI]
|
1.31147e-08
|
|
|
APRT
|
[NCBI]
|
1.25533e-08
|
|
|
SHH
|
[NCBI]
|
6.34622e-09
|
|
|
SDC2
|
[NCBI]
|
1.25055e-09
|
|
|
TLR4
|
[NCBI]
|
5.49521e-10
|
|